220 related articles for article (PubMed ID: 22848234)
21. Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.
Zhong W; Chen S; Qin Y; Zhang H; Wang H; Meng J; Huai L; Zhang Q; Yin T; Lei Y; Han J; He L; Sun B; Liu H; Liu Y; Zhou H; Sun T; Yang C
Oncotarget; 2017 Dec; 8(62):104855-104866. PubMed ID: 29285218
[TBL] [Abstract][Full Text] [Related]
22. Protease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction.
Chmelař J; Kotál J; Langhansová H; Kotsyfakis M
Front Cell Infect Microbiol; 2017; 7():216. PubMed ID: 28611951
[TBL] [Abstract][Full Text] [Related]
23. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
[TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.
Li SM; Jiang P; Xiang Y; Wang WW; Zhu YC; Feng WY; Li SD; Yu GY
Dongwuxue Yanjiu; 2014 Sep; 35(5):420-5. PubMed ID: 25297082
[TBL] [Abstract][Full Text] [Related]
25. Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.
Marcucci G; Yan P; Maharry K; Frankhouser D; Nicolet D; Metzeler KH; Kohlschmidt J; Mrózek K; Wu YZ; Bucci D; Curfman JP; Whitman SP; Eisfeld AK; Mendler JH; Schwind S; Becker H; Bär C; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Byrd JC; Plass C; Garzon R; Caligiuri MA; Stone RM; Volinia S; Bundschuh R; Bloomfield CD
J Clin Oncol; 2014 Feb; 32(6):548-56. PubMed ID: 24378410
[TBL] [Abstract][Full Text] [Related]
26. CCL2 at the crossroad of cancer metastasis.
Eferl R
JAKSTAT; 2013 Apr; 2(2):e23816. PubMed ID: 24058811
[TBL] [Abstract][Full Text] [Related]
27. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin.
Etulain J; Fondevila C; Negrotto S; Schattner M
Br J Pharmacol; 2013 Sep; 170(2):255-65. PubMed ID: 23713888
[TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor 4: a critical participator in inflammatory response.
Fu Q; Cheng J; Gao Y; Zhang Y; Chen X; Xie J
Inflammation; 2015 Apr; 38(2):886-95. PubMed ID: 25120239
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptors in cancer: A systematic review.
Han N; Jin K; He K; Cao J; Teng L
Oncol Lett; 2011 Jul; 2(4):599-608. PubMed ID: 22848234
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
31. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
33. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
34. Cofactoring and dimerization of proteinase-activated receptors.
Lin H; Liu AP; Smith TH; Trejo J
Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
[TBL] [Abstract][Full Text] [Related]
35. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
